Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson’s disease
- 25 October 2010
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 124 (3) , 211-214
Abstract
Evidente VGH, Premkumar AP, Adler CH, Caviness JN, Driver‐Dunckley E, Lyons MK. Medication dose reductions after pallidal versus subthalamic stimulation in patients with Parkinson’s disease.Acta Neurol Scand: 2011: 124: 211–214.© 2010 John Wiley & Sons A/S. Objective – To compare the medication dose reduction between deep brain stimulation (DBS) of the globus pallidus interna (GPi) vs subthalamic nucleus (STN) in matched patients with Parkinson’s disease (PD). Materials and methods – Records of 12 patients with PD who underwent GPi‐DBS at our institution from 2002 to 2008 were matched by pre‐operative PD medication doses and pre‐operative motor Unified Parkinson’s Disease Rating Scale (UPDRS) scores to 12 cases of STN‐DBS. PD medication doses were converted to levodopa equivalent doses (LEDs). Results – GPi and STN groups had similar mean pre‐operative LEDs and motor UPDRS scores. At 6 months post‐DBS, there was no significant difference in percent reduction in LEDs between the GPi (47.95%) and STN (37.47%) groups (P = 0.52). The mean post‐operative ‘medication off/stimulation on’ motor UPDRS scores did not differ significantly between GPi (15.33) and STN (16.25) groups (P = 0.74). The mean percent reduction in motor UPDRS scores was also similar between GPi (58.44%) and STN (58.98%) patients (P = 0.94). Conclusions – We conclude that in disease‐matched patients with PD undergoing DBS, both GPi and STN may result in similar reduction in PD medication doses.Keywords
This publication has 12 references indexed in Scilit:
- Pallidal versus Subthalamic Deep-Brain Stimulation for Parkinson's DiseaseNew England Journal of Medicine, 2010
- Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: The COMPARE TrialAnnals of Neurology, 2009
- Deep brain stimulation for Parkinson's disease: Prevalence of adverse events and need for standardized reportingMovement Disorders, 2007
- Pallidal vs Subthalamic Nucleus Deep Brain Stimulation in Parkinson DiseaseArchives of Neurology, 2005
- Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias?Journal of Neurology, Neurosurgery & Psychiatry, 2005
- Deep Brain Stimulation for Parkinson’s DiseaseStereotactic and Functional Neurosurgery, 2002
- Deep-Brain Stimulation of the Subthalamic Nucleus or the Pars Interna of the Globus Pallidus in Parkinson's DiseaseNew England Journal of Medicine, 2001
- Deep brain stimulation for the treatment of Parkinson's disease: subthalamic nucleus versus globus pallidus internusJournal of Neurology, Neurosurgery & Psychiatry, 2001
- Safety and efficacy of pallidal or subthalamic nucleus stimulation in advanced PDNeurology, 2001
- Comparison of Pallidal and Subthalamic Nucleus Deep Brain Stimulation for Advanced Parkinson's Disease: Results of a Randomized, Blinded Pilot StudyNeurosurgery, 1999